Telefon LinkedIn
NeoPrediX PRESENT AT BIOTECH SHOWCASE™ 2022

Breakthrough Prediction Software Platform of NeoPrediX shown at BIOTECH SHOWCASE

ein guter alternativer Titel für das Bild

 

Regensburg, Germany. 22nd of December 2021 – NeoPrediX today announced that it will be presenting virtually at the Biotech Showcase™ 2022 conference with an online presentation. This year, registered attendees to Biotech Showcase can access NeoPrediX’ recorded company presentation already starting the week of December 6th – five weeks prior to the actual event. 24x7 on-demand access allows attendees to view presentations at their convenience in case scheduling does not allow participation during the main event week.

Thorsten Waloschek will be presenting NeoPrediX at Biotech Showcase

NeoPrediX develops decision support tools with maternal, neonatal and perinatal screening platforms to evaluate, optimize and personalize medical strategies in pediatrics. We utilize intelligent algorithms and digital health solutions for neonatal and perinatal care based on deep medical data and science, developed by experienced scientists, pediatricians, and neonatologists. We transform medical data into intelligent predictions to support clinical decisions.

Biotech Showcase, produced by Demy-Colton and EBD Group, is an investor conference focused on driving advances in therapeutic development by providing a sophisticated networking platform for executives and investors that fosters investment and partnership opportunities. The conference takes place each year during the course of one of the industry's largest gatherings and busiest weeks.

“We are delighted that NeoPrediX will be presenting at Biotech Showcase this year,” said Sara Demy, CEO of Demy-Colton. “Biotech Showcase is a prime occasion for life science entrepreneurs and investors to come together to discover the potential of innovative technologies that will drive the future of drug discovery.”

 

ABOUT BIOTECH SHOWCASE

Biotech Showcase is an investor and networking conference devoted to providing private and public biotechnology and life sciences companies with an opportunity to present to, and meet with, investors and pharmaceutical executives in one place. Investors and biopharmaceutical executives from around the world gather at Biotech Showcase during this bellwether week which sets the tone for the coming year. Now in its 14th year, this well-established, highly respected conference features multiple tracks of presenting companies, plenary sessions, workshops, networking, and an opportunity to schedule one-to-one meetings. Biotech Showcase is produced by Demy-Colton and EBD Group. Both organizations have a long history of producing high-quality programs that support the biotechnology and broader life sciences industry.

ABOUT NeoPrediX

NeoPrediX AG was founded in 2020 as a spin-off from the University of Basel. A diverse, highly motivated team driven by desire for achievement and passion for children increased by 17 employees. By end of 2021 NeoPrediX has offices in Regensburg, Switzerland (Basel) and the USA (Fort Lauderdale). The company develops a software platform which helps clinicans and medical staff to identify, predict and treat perinatal (period between the 22nd week of pregnancy and 7 days after birth) and neonatal (period from birth to around four weeks after the corrected due date) diseases at an early stage and possible complications. NeoPrediX develops digital health solutions based on intelligent algorithms. These are based on large amounts of medical data and years of academic and scientific research.

Contacts

Thorsten Waloschek
CEO
Diese E-Mail-Adresse ist vor Spambots geschützt! Zur Anzeige muss JavaScript eingeschaltet sein!

Lisa Brimm
Marketing Manager
Diese E-Mail-Adresse ist vor Spambots geschützt! Zur Anzeige muss JavaScript eingeschaltet sein!

zurück